AptarGroup (ATR)
(Delayed Data from NYSE)
$153.19 USD
+0.91 (0.60%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $153.04 -0.15 (-0.10%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth F Momentum D VGM
Price, Consensus and EPS Surprise
ATR 153.19 +0.91(0.60%)
Will ATR be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ATR based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ATR
Berry Global Stock Boasts Strong Prospects Despite Headwinds
Greif Q3 Earnings Miss Estimates, Sales Beat on Higher Volumes
ATR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zacks Industry Outlook Highlights Packaging Corporation of America, Brambles, AptarGroup and Greif
4 Containers - Paper and Packaging Stocks to Buy in a Promising Industry
AptarGroup Hits 52-Week High: What's Driving the Stock's Performance?
Other News for ATR
Insider Sale: Segment President Marc Prieur Sells 3,500 Shares of AptarGroup Inc (ATR)
Stevanato Group SPA's Meteoric Rise: Unpacking the 17% Surge in Just 3 Months
Insider Sale: Chief Human Resources Officer Shiela Vinczeller Sells Shares of AptarGroup Inc (ATR)
SMMV: Best Of Breed Low-Vol ETF In Small Caps
Aptar?s Nasal Unidose System to Deliver neffy? (epinephrine nasal spray), the First and Only FDA-Approved Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis